3D Stack HepG2 Liver-chip-model
Enhanced Hepatic Function on 3D Stack Liver Model
Imaging of cells through 3D stacked liver-chip layers
Cells were imaged live on day 3 in stacked layers using epi-fluorescent microscopy (10x magnification). Labling: HUVEC with Cell Tracker (Green, CMFDA), HepG2 cells with Cell Tracker (Red, CMTPX) and NIN/3T3 cells with Hoechst stain. Cells can be easy imaged through layers by standard inverted microscope
Metabolism in HepG2 hepatocytes
CYP3A4 expression levels in monoculture hepatocytes vs. tri-culture stacked set-up in CELLBLOKS®. In HepG2 heptocyes CYP3A4 activity increased 3 times compared to HepG2 monocultures.
Metabolism in human upcyte® primary hepatocytes
CYP3A4 expression levels in monoculture hepatocytes vs. tri-culture stacked set-up in CELLBLOKS®. In tri-culture model CYP3A4 in primary hepatocytes is enhanced by up to 3 times compared to monoculture hepatocytes over the 12 day of culture
Powerful Drug Induced Liver Injury (DILI) prediction capability
CELLBLOKS® 3D stack Liver-on-a-Chip model clearly distinguishes between hepatotoxic vs. their no-toxic structural analogues drugs at clinically relevant concentrations
Hepatotoxicity evaluation (24 h exposure) in CELLBLOKS® NANOSTACK™ based 3D liver model
Hepatotoxic drug-induced toxicity in HepG2 cells can be detected at concentrations < 10 µM over human plasma Cmax levels. The model correctly differentiated the hepatotoxic effects of compounds at high DILI concern (Clozapine, Troglitazone, Trovafloxacin) as opposed to their non-toxic drug analogues (respectively Olanzapine, Pioglitazone, Levofloxacin) at clinically relevant concentrations, therefore demonstrating arobust DILI prediction capability.
Frequency Bought Together
Need some help?
If you're interested in discovering how CELLBLOKS® OOC can benefit your research, we invite you to get in touch with us. Our team is available to provide further insights and address any inquiries you may have. Feel free to explore the following contact options: